Y-mAbs Therapeutics
YMAB
#7264
Rank
S$0.49 B
Marketcap
$11.06
Share price
0.49%
Change (1 day)
12.76%
Change (1 year)

Earnings for Y-mAbs Therapeutics (YMAB)

Earnings in 2024 (TTM): -S$37.8 Million

According to Y-mAbs Therapeutics 's latest financial reports the company's current earnings are S$84.55 Million. In 2023 the company made an earning of -S$34.84 Million, an increase over its 2022 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Y-mAbs Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$37.8 Million8.49%
2023 -S$34.84 Million-72.92%
2022 -S$0.13 Billion77.47%
2021 -S$72.51 Million-55.46%
2020 -S$0.17 Billion44.49%
2019 -S$0.12 Billion92.01%
2018 -S$58.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.19 Billion 373.42%๐Ÿ‡บ๐Ÿ‡ธ USA